FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska | Q&A with FDA
In this episode of Q&A with FDA, we hear from Dr. Marta Sokolowska, Deputy Center Director for Substance Use and Behavioral Health in FDA’s Center for Drug Evaluation and Research, discuss the Agency’s vision as it relates to encouraging harm reduction, including expanding availability and access to lifesaving overdose reversal products. Dr. Sokolowska delves into the impacts of the recent approvals of nonprescription naloxone nasal spray as well as prescription nalmefene nasal spray, another medication for opioid overdose.
You May Also Like

RDN Radio – Roma Daily News
Radio RDN - RomaDailyNews

BSD Now
JT Pennington

Las noticias de la SER
SER Podcast
The Podcast of the Lotus Eaters
lotuseaters.com

444 podcastek
444

Asmongold TV
Asmongold TV
Newshour
BBC World Service

The Diddy Diaries
Bobby Capucci

Even Money: NFL Betting Podcast
Betting, Sports Betting, Gambling, NFL Betting

Siste nytt fra VG
VG
Community discussion